Article

OTC MEVACOR GETS THUMBS DOWN AGAIN-January 2008

Merck & Co Inc's third bid

Related Videos
Image credit: Photo18@desing | stock.dobe.com
Related Content
Woman experiencing migraine-related pain -- Image credit: goodluz | stock.adobe.com
May 1st 2025

FDA Approves Atzumi, Nasal Powder Formulation of DHE, for Acute Treatment of Migraine

Gillian McGovern, Associate Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Respiratory Virus Genetic Material Micrograph - Image credit: GOLVR | stock.adobe.com
May 1st 2025

Adult RSV-ARI Linked to Higher Death Risk and Health Care Costs

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Next-generation sequencing | Image Credit: © Supaporn - stock.adobe.com
April 30th 2025

Biomarker Testing Transforms NSCLC Care, But Gaps Persist in Community Settings

Alexandra Gerlach, Associate Editor
OTC Case Studies In Pain Management
April 30th 2025

OTC Case Studies In Pain Management

Sneha Baxi Srivastava, PharmD, BCACP, CDCES, DipACLM, FADCES Rupal Patel Mansukhani, PharmD, FAPhA, NCTTP